Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 6 , Pages 753-767 , December 2009

Medications that distort in vitro tests of thyroid function, with particular reference to estimates of serum free thyroxine

  • Jim R. Stockigt, MD, FRACP, FRCPA (Professor of Medicine, Consultant Endocrinologist)

      Affiliations

    • Monash University, Melbourne, Australia
    • Epworth and Alfred Hospitals, Melbourne, Australia
    • Corresponding Author InformationCorresponding author. Monash University, Melbourne, Australia.
    • ,
  • Chen-Fee Lim, MAACB, MAgrSci, PhD (Head of Immunoassay Laboratory)

      Affiliations

    • Dorevitch Pathology, Melbourne, Australia

References 

  1. Refetoff S, Dimitruescu AM. Syndromes of reduced sensitivity to thyroid hormone; genetic defects in hormone receptors, cell transporters and deiodination. Best Practice & Research. Clinical Endocrinology & Metabolism. 2007;21:277–305
  2. Oliviera JHA, Persani L, Beck-Peccoz P, et al. Investigating the paradox of hypothyroidism and increased TSH levels in Sheehan's syndrome: characterization of TSH carbohydrate content and bioactivity. The Journal of Clinical Endocrinology and Metabolism. 2001;86:1694–1699
  3. Beck-Peccoz P, Persani L. Variable biological activity of thyroid stimulating hormone. European Journal of Endocrinology. 1994;131:331–340
  4. Stockigt JR. Thyroid function tests and the effect of drugs. In:  Wass JAH,  Shalet SM editor. Oxford textbook of endocrinology and diabetes. OUP; 2002;p. 306–316
  5. Mebis L, Debaveye Y, Visser TJ, et al. Changes within the thyroid axis during the course of critical illness. Endocrinology and Metabolism Clinics of North America. 2006;35:807–821
  6. Surks MI, Sievert R. Drugs and thyroid function. The New England Journal of Medicine. 1995;333:1688–1694
  7. National Academy of Clinical Biochemistry . Laboratory support for the diagnosis of thyroid disease. http://www.aacc.org/members/nacb/archive/lmpg/thyroiddisease/pages/default.aspx
  8. Lando VS, Batista MC, Nakamura IT, et al. Effects of long-term storage of filter paper blood samples on neonatal thyroid stimulating hormone, thyroxin and 17-alpha-hydroxyprogesterone measurements. Journal of Medical Screening. 2008;15:109–111
  9. Hebles-Duvison M, Cruz-Ruiz M, Vazquez-Rubio R, et al. Evaluation of AutoDelfia and access automated immunoassay systems for third generation assays for thyrotropin. European Journal of Clinical Chemistry and Clinical Biochemistry. 1995;33:881–885
  10. Despres N, Grant AM. Antibody interference in thyroid assays: a potential for clinical misinformation. Clinical Chemistry. 1998;44:440–454
  11. Kricka LJ. Interferences in immunoassays – still a threat. Clinical Chemistry. 2000;46:10037–10038
  12. Ward G, Mckinnon L, Badrick T, et al. Heterophilic antibody remains a problem for the immunoassay laboratory. American Journal of Clinical Pathology. 1997;108:417–421
  13. Hunter WM, Bennie JG, Budd PS, et al. Immunometric assays using monoclonal antibodies. In:  Hunter WM,  Corrie JET editor. Immunoassays for clinical chemistry. Edinburgh: Churchill-Livingston; 1983;p. pp531–pp544
  14. Scantibodies laboratories . http://www.scantibodies.com/block.html
  15. Bjerner J, Nustad K, Norum LF, et al. Immunometric assay interference: incidence and prevention. Clinical Chemistry. 2002;48:613–621
  16. Ross HA, Menheere PPCA, Thomas CMG, et al. Interference from heterophilic antibodies in seven current TSH assays. Annals of Clinical Biochemistry. 2008;45:616
  17. Flad TM, Duffy J, McKenna TJ. Multiple spuriously abnormal thyroid function indices due to heterophilic antibodies. Clinical Endocrinology. 1994;41:391–395
  18. Sakata S, Nakamura S, Miura K. Autoantibodies against thyroid hormones or iodothyronine. Annals of Internal Medicine. 1985;103:579–589
  19. Beck-Peccoz P, Romelli PB, Cattaneo MG, et al. Evaluation of free T4 methods in the presence of iodothyronine autoantibodies. The Journal of Clinical Endocrinology and Metabolism. 1984;58:736–739
  20. Stockigt JR, Stevens V, White EL, et al. “Unbound analog” radioimmunoassays for free thyroxin measure the albumin-bound hormone fraction. Clinical Chemistry. 1983;29:1408–1410
  21. Iitaka M, Kawasaki S, Sakurai S, et al. Serum substances that interfere with thyroid hormone assays in patients with chronic renal failure. Clinical Endocrinology. 1998;48:739–746
  22. Stockigt JR, Lim C-F, Barlow JW, et al. Interaction of furosemide with serum thyroxine-binding sites: in vivo and in vitro studies and comparison with other inhibitors. The Journal of Clinical Endocrinology and Metabolism. 1985;60:1025–1031
  23. Stockigt JR, Lim C-F, Barlow JW, et al. Thyroid hormone transport. In:  Weetman AP,  Grossman A editor. Pharmacotherapeutics of the thyroid gland. Heidelberg: Springer Verlag; 1997;p. 119–150
  24. Munro SL, Lim C-F, Hall JG, et al. Drug competition for thyroxine binding to transthyretin (prealbumin): comparison with effects on thyroxine-binding globulin. The Journal of Clinical Endocrinology and Metabolism. 1989;68:141–147
  25. Ekins R. The free hormone hypothesis and measurement of free hormones. Clinical Chemistry. 1992;38:1289–1293
  26. Surks MI, Hupart KH, Chao P, et al. Normal free thyroxine in critical nonthyroidal illnesses measured by ultrafiltration of undiluted serum and equilibrium dialysis. The Journal of Clinical Endocrinology and Metabolism. 1988;67:1031–1039
  27. Surks MI, Defesi CR. Normal free thyroxine concentrations in patients treated with phenytoin or carbamazepine: a paradox resolved. The Journal of the American Medical Association. 1996;275:1495–1498
  28. Ekins R. Measurement of free hormones in blood. Endocrine Reviews. 1990;11:5–46
  29. Stockigt JR. Thyroid hormone binding and variants of transport proteins. In:  DeGroot LJ,  Jameson L editor. Endocrinology. 5th edn. Philadelphia: WB Saunders; 2006;p. 2215–2226
  30. Mendel CM, Frost PH, Cavalieri RR. Effect of free fatty acids on the concentration of free thyroxine in human serum: the role of albumin. The Journal of Clinical Endocrinology and Metabolism. 1986;63:1394–1399
  31. Lim C-F, Bai Y, Topliss DJ, et al. Drug and fatty acid effects on serum thyroid hormone binding. The Journal of Clinical Endocrinology and Metabolism. 1988;67:682–688
  32. Stockigt JR, Lim CF, Barlow JW, et al. High concentrations of furosemide inhibit serum binding of thyroxine. The Journal of Clinical Endocrinology and Metabolism. 1984;59:62–66
  33. Hawkins RC. Furosemide interference in newer free thyroxine assays. Clinical Chemistry. 1998;44:2550–2551
  34. Lim C-F, Wynne KN, Barned JM, et al. Non-isotopic spectrophotometric determination of the unbound fraction of drugs in serum. The Journal of Pharmacy and Pharmacology. 1986;38:795–800
  35. Sterling K, Brenner MA. Free thyroxine in human serum: simplified measurement with aid of magnesium precipitation. The Journal of Clinical Investigation. 1966;45:153–163
  36. Mendel CM, Frost PH, Kunitake ST, et al. Mechanism of the heparin-induced increase in the concentration of free thyroxine in plasma. The Journal of Clinical Endocrinology and Metabolism. 1987;65:1259–1264
  37. Zambon A, Hashimoto SI, Brunzell JD. Analysis of techniques to obtain plasma for measurement of levels of free fatty acids. Journal of Lipid Research. 1993;34:1021–1028
  38. Jaume JC, Mendel CM, Frost PH, et al. Extremely low doses of heparin release lipase activity into the plasma and can thereby cause artefactual elevations in the serum free thyroxine concentrations as measured by equilibrium dialysis. Thyroid. 1996;6:79–83
  39. Stevenson HP, Archbold GPR, Johnston P, et al. Misleading serum free thyroxine results during low molecular weight heparin treatment. Clinical Chemistry. 1998;44:1002–1007
  40. Lim C-F, Curtis AJ, Barlow JW, et al. Interactions between oleic acid and drug competitors influence specific binding of thyroxine in serum. The Journal of Clinical Endocrinology and Metabolism. 1991;73:1106–1110
  41. Lim C-F, Stockigt JR, Curtis AJ, et al. Influence of a naturally-occurring furanoid acid on the potency of drug competitors for specific thyroxine binding in serum. Metabolism. 1993;42:1468–1474
  42. Newnham HH, Hamblin PS, Long F, et al. Effect of oral furosemide on diagnostic indices of thyroid function. Clinical Endocrinology. 1987;26:423–431
  43. Wang R, Nelson JC, Wilcox RB. Salsalate administration as a potential pharmacological model of the sick euthyroid syndrome. The Journal of Clinical Endocrinology and Metabolism. 1998;83:3095–3099
  44. Chopra IJ, Huang TS, Beredo A, et al. Serum thyroid hormone binding inhibitor in non-thyroidal illness. Metabolism. 1986;35:152–159
  45. Chopra IJ, Huang TS, Solomon DH, et al. The role of thyroxine-binding serum proteins in oleic acid-induced increase in free T4 in nonthyroidal illness. The Journal of Clinical Endocrinology and Metabolism. 1986;63:776–779
  46. Mendel CM, Laughton CW, McMahon FA, et al. Inability to detect an inhibitor to thyroxine-serum protein binding in sera from patients with nonthyroidal illness. Metabolism. 1991;40:491–502
  47. Jirasakuldech B, Schussler GC, Yap MG, et al. A characteristic serpin cleavage product of thyroxine-binding globulin appears in sepsis sera. The Journal of Clinical Endocrinology and Metabolism. 2000;85:3996–3999
  48. Janssen OE, Golcher HM, Grasberger H, et al. Characterization of T4-binding globulin cleaved by human elastase. The Journal of Clinical Endocrinology and Metabolism. 2002;87:1217–1222
  49. Sapin R, Schlienger J-L, Gasser F, et al. Intermethod discordant free thyroxine measurements in bone marrow-transplanted patients. Clinical Chemistry. 2000;46:418–422
  50. Kaptein EM. Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocrine Reviews. 1996;17:45–63
  51. Glinoer D. Thyroid disease manager. Chapter 14. Thyroid regulation and dysfunction in the pregnant patient. www:thyroidmanager.org
  52. Ball R, Freeman DB, Holmes JC, et al. Low-normal concentrations of free thyroxine in late pregnancy; physiological fact, not technical artefact. Clinical Chemistry. 1989;35:1891–1896
  53. Roti E, Gardini E, Minelli R, et al. Thyroid function evaluation by different commercially available free thyroid hormone measurement kits in term pregnant women and their newborns. Journal of Endocrinological Investigation. 1991;14:1–9
  54. Lee RH, Spencer CA, Mestman JH, et al. Free T4 assays are flawed during pregnancy. American Journal of Obstetrics and Gynecology. 2009;260:260e1–260e6
  55. Sivan E, Homko CJ, Whittaker PG, et al. Free fatty acids and insulin resistance during pregnancy. The Journal of Clinical Endocrinology and Metabolism. 1998;83:2338–2342
  56. Yue B, Rockwood AL, Sandrock T, et al. Free thyroid hormones in serum by direct equilibrium dialysis and on-line solid-phase extraction-liquid chromatography/tandem mass spectrometry. Clinical Chemistry. 2008;54:642–651
  57. Thienpont LM. A major step forward in the routine measurement of serum free thyroid hormones. Clinical Chemistry. 2008;54:625–626
  58. Van den Berghe G, de Zegher F, Baxter RC, et al. Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. The Journal of Clinical Endocrinology and Metabolism. 1998;83:309–319
  59. Van den Berghe G, Wouters P, Weekers F, et al. Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone releasing peptides and thyrotropin releasing hormone in patients with protracted critical illness. The Journal of Clinical Endocrinology and Metabolism. 1999;84:1311–1323
  60. Stockigt JR. Thyroid disease manager. Chapter 6b. Clinical strategies in the testing of thyroid function. Section 6. The physician–laboratory interface. www:thyroidmanager.org

PII: S1521-690X(09)00073-6

doi: 10.1016/j.beem.2009.06.004

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 6 , Pages 753-767 , December 2009

Article Tools

* Image Usage & Resolution